CEO Al Ganier says startup exhaustively considered market priority, and might later address opioid users' risk of pregnancy.
[updated] Expanding portfolios, going into CEO Charlie Brock's third year onboard.
The Row's Galante eyes startups and Crom's at it again, as well as Ganier, Van Hoesen and others.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: